Box Office Report :: January 26 – 28

20th Century Fox

There wasn’t a lot of action at the box office this weekend with just one new wide release, but two films continue to defy the odds while expansions also brought two other films into the Top Ten.

Checking in at Number 1 was the third and final film in the Maze Runner trilogy Maze Runner: The Death Cure. The film opened on 3,787 screens and earned $24.1 million domestically against a $62 million budget. Unfortunately, that debut was off $7 million from part two and $9 million down from the first film suggesting that it’s only playing to the fans of the first two movies. The film’s release was delayed by almost a year due to an on-set injury sustained by star Dylan O’Brien, so that probably didn’t help.

The Death Cure opened internationally last weekend and earned $15 million in four markets. It expanded this weekend to more than 70 markets, earning an estimated $62.7 million, bringing its global total to $108.1 million.

There was another new entry into the Top Ten with the limited release of Padmaavat on 324 screens. It took the Number 10 spot with $4.4 million, a $13,674 per screen average, the highest in the Top 50. By comparison, The Death Cure‘s average was $6,382, the second highest of the weekend.

Still performing after six weeks, Jumaji: Welcome to the Jungle dropped just 17% and moved down on notch to Number 2 with $16.1 million. Domestically the film has now earned $337.8 million, making it Sony’s third most successful film of all time, surpassing Spider-Man 3 and Spider-Man: Homecoming. Globally the film has earned $821.8 million, ranking as Sony’s fifth most successful film worldwide.

Also hanging in there after six weeks is the little film that could, The Greatest Showman, dropping just 10% and moving back up to the Number 4 spot this week with $9.5 million. The film’s domestic total stands at $126.5 million with a worldwide gross of $259.5 million.

Hostiles added 2,697 screens (total 2,816) and received a 1,642% boost, flying up the charts from Number 23 to Number 3 with $10.1 million. Also in its sixth week of release the expansion brings the film’s domestic total to $12 million.

A combination of 13 Oscar nominations and an expansion of 1,001 screens (total 1,854) gave The Shape of Water a 171% boost, rising from Number 16 to Number 8 with $5.9 million. After nine weeks of release, the film has earned $37.9 million domestically and $51.8 million worldwide.

Both 12 Strong and Den of Thieves saw 40+% drops in their second week of release. 12 Strong (-45%) fell from Number 2 to Number 6 with $8.68 million and Den of Thieves (-43%) went from Number 3 to Number 7 with $8.63 million. And Star Wars: The Last Jedi exited the Top Ten, falling three spots to Number 11 with $4.2 million and a domestic total of $610.7 million.

February 2 is going to be another slow weekend with just Winchester opening on about 2,300 screens … and several major markets aren’t even getting advance screenings so that could be a bad sign that means the studio is hoping curiosity will drag people in opening weekend without advance word of mouth killing its prospects. Color us disappointed.

Below are the Top Ten grosses for the weekend of January 26.

1. [N] –1Maze Runner: The Death Cure – $24,167,011 [NEW] – ★★★

2. [1] –6Jumanji: Welcome to the Jungle – $16,144,874 [$337,802,077] – ★★✩

3. [23] –6Hostiles – $10,110,739 [$11,958,534] – ★★✩

4. [5] –6The Greatest Showman – $9,550,367 [$126,525,599]

5. [4] –6The Post – $9,107,141 [$58,793,064] – ★★★

6. [2] –212 Strong – $8,686,066 [$29,810,676] – ★★✩

7. [3] –2Den of Thieves – $8,632,808 [$28,775,253]

8. [16] –9The Shape of Water – $5,922,553 [$37,901,298] – ★★★

9. [6] –3Paddington 2 – $5,668,433 [$32,118,849]

10. [N] –1Padmaavat – $4,430,255 [$4,937,521]

[#] Last week’s position. [N] New in theaters. – # – Weeks in theaters. HOTCHKA review  |  Source: Box Office Mojo

Previous Post
Next Post


Share this post
Tweet about this on TwitterShare on FacebookShare on Tumblr

Leave a Reply

Your email address will not be published. Required fields are marked *